Hadassah Sees Promising Results in Antibody Treatment for COVID-19

Tuesday, Aug 18 2020

The Hadassah Medical Organization (HMO), together with the Israeli biopharmaceutical firm Kamada, is currently testing a “passive vaccine” that is showing promising therapeutic results in patients with COVID-19. The first patients treated have already been released from the hospital and have returned home.

Patients with any viral disease develop antibodies in their plasma that help fight off the disease. Hadassah’s Blood Bank collected plasma from recovered COVID-19 patients and transferred that plasma to Kamada, which used it to produce the appropriate antibodies, what it calls its “anti-SARS-CoV-2 plasma-derived immunoglobulin (IgG) product.”

According to HMO Director General Prof. Zeev Rotstein, the treatment is being given to seriously ill COVID-19 patients. Potentially, it could also stop the progression of disease in high-risk patients who contract the virus.

What makes passive immunization different from an active vaccine is that a passive vaccine uses antibodies from recovered patients while an active vaccine contains a dead or weakened version of an actual virus.

To read more, click here.

Related Stories


Wednesday, Sep 16 2020

Hadassah to Conduct Clinical Trial of Israeli-Made COVID-19 Vaccine

The Hadassah Medical Organization is slated to begin a clinical trial with an Israeli-made COVID-19 vaccine in October. One hundred volunteers are being recruited to participate at Hadassah and Tel Aviv’s Sheba Medical Center.


Tuesday, Sep 15 2020

Where Others Gave Up: Hadassah Liver Specialists Save a Father’s Life

Many doctors predicted that Amir Hazan, a 46-year-old father of two, would live for only two years. First diagnosed in 2011 with cirrhosis of the liver, he experienced a rapid decline in his health about a year ago.


Tuesday, Sep 15 2020

Hadassah Forging Ties With Medical Professionals As UAE, Bahrain Recognize Israel

Hadassah, The Women’s Zionist Organization of America, Inc. National President Rhoda Smolow released the following statement today following the signing of the Abraham Accords...


Monday, Sep 14 2020

Judean Palm Dates Make a Comeback After 2000 Years, Thanks to HMO Doctor’s Quest

As a pediatric gastroenterologist and Director of the Louis L. Borick Natural Medicine Research Center at the Hadassah Hospital Ein Kerem in Jerusalem, Dr. Sarah Sallon has long been interested in natural remedies.


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Israel Travel


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005


More ›

Show More